Thrombospondin-1 Restricts Interleukin-36γ-Mediated Neutrophilic Inflammation during Pseudomonas aeruginosa Pulmonary Infection
暂无分享,去创建一个
Janet S. Lee | T. Standiford | J. Ybe | C. Zou | J. Alder | Z. Xiong | M. Hulver | M. Newstead | Yanyan Qu | W. Bain | H. Peñaloza | R. van der Geest | T. Olonisakin | J. Zupetic
[1] A. Delmas,et al. Imaging of extracellular cathepsin S activity by a selective near infrared fluorescence substrate-based probe. , 2019, Biochimie.
[2] J. Kos,et al. Cysteine Cathepsins in Tumor-Associated Immune Cells , 2019, Front. Immunol..
[3] A. Oliver,et al. Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections , 2019, Clinical Microbiology Reviews.
[4] Richard A. Stanton,et al. Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015 , 2019, Emerging infectious diseases.
[5] J. Wenzel,et al. Interleukin-36 in Infectious and Inflammatory Skin Diseases , 2019, Front. Immunol..
[6] T. Kohler,et al. Contribution of Human Thrombospondin-1 to the Pathogenesis of Gram-Positive Bacteria , 2019, Journal of Innate Immunity.
[7] Janet S. Lee,et al. Platelets inhibit apoptotic lung epithelial cell death and protect mice against infection-induced lung injury , 2019, Blood advances.
[8] C. Calfee,et al. Phenotypes in acute respiratory distress syndrome: moving towards precision medicine , 2019, Current opinion in critical care.
[9] T. Standiford,et al. Overlapping Roles for Interleukin-36 Cytokines in Protective Host Defense against Murine Legionella pneumophila Pneumonia , 2018, Infection and Immunity.
[10] A. Jamieson,et al. Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System , 2018, Front. Immunol..
[11] Seamus J. Martin,et al. Extracellular Neutrophil Proteases Are Efficient Regulators of IL-1, IL-33, and IL-36 Cytokine Activity but Poor Effectors of Microbial Killing. , 2018, Cell reports.
[12] Seamus J. Martin,et al. Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases , 2018, Cell Death & Disease.
[13] Janet S. Lee,et al. Thrombospondin-1 protects against pathogen-induced lung injury by limiting extracellular matrix proteolysis. , 2018, JCI insight.
[14] William A. Mattingly,et al. Adults Hospitalized With Pneumonia in the United States: Incidence, Epidemiology, and Mortality , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] T. Standiford,et al. Interleukin-36γ and IL-36 receptor signaling mediate impaired host immunity and lung injury in cytotoxic Pseudomonas aeruginosa pulmonary infection: Role of prostaglandin E2 , 2017, PLoS pathogens.
[16] Yibing Yin,et al. IL‐36 induces cytokine IL‐6 and chemokine CXCL8 expression in human lung tissue cells: Implications for pulmonary inflammatory responses , 2017, Cytokine.
[17] M. Rybak,et al. Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors. , 2017, Diagnostic microbiology and infectious disease.
[18] A. Alase,et al. Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ , 2017, Proceedings of the National Academy of Sciences.
[19] Dima Kozakov,et al. New additions to the ClusPro server motivated by CAPRI , 2017, Proteins.
[20] B. Kazmierczak,et al. Inflammation: A Double-Edged Sword in the Response to Pseudomonas aeruginosa Infection , 2017, Journal of Innate Immunity.
[21] T. Standiford,et al. IL-36γ is a crucial proximal component of protective type-1-mediated lung mucosal immunity in Gram-positive and -negative bacterial pneumonia , 2017, Mucosal Immunology.
[22] Dima Kozakov,et al. The ClusPro web server for protein–protein docking , 2017, Nature Protocols.
[23] Janet S. Lee,et al. IL-17 Receptor Signaling in the Lung Epithelium Is Required for Mucosal Chemokine Gradients and Pulmonary Host Defense against K. pneumoniae. , 2016, Cell host & microbe.
[24] J. Ybe,et al. Structural and Functional Attributes of the Interleukin-36 Receptor* , 2016, The Journal of Biological Chemistry.
[25] Anders Larsson,et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.
[26] Seamus J. Martin,et al. Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines. , 2016, Cell reports.
[27] Bill B. Chen,et al. Thrombospondin-1 restrains neutrophil granule serine protease function and regulates the innate immune response during Klebsiella pneumoniae infection , 2014, Mucosal Immunology.
[28] E. Sundberg,et al. Molecular Determinants of Agonist and Antagonist Signaling through the IL-36 Receptor , 2014, The Journal of Immunology.
[29] G. Taraboletti,et al. Current understanding of the thrombospondin-1 interactome. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[30] J. Gudjonsson,et al. IL-36 Promotes Myeloid Cell Infiltration, Activation, and Inflammatory Activity in Skin , 2013, The Journal of Immunology.
[31] Feng Zhao,et al. Protein threading using context-specific alignment potential , 2013, Bioinform..
[32] Robert E Black,et al. Global burden of childhood pneumonia and diarrhoea , 2013, The Lancet.
[33] Jian Peng,et al. Template-based protein structure modeling using the RaptorX web server , 2012, Nature Protocols.
[34] Jian Peng,et al. A conditional neural fields model for protein threading , 2012, Bioinform..
[35] J. Lawler,et al. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. , 2012, Cold Spring Harbor perspectives in medicine.
[36] M. Sweetwyne,et al. Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms. , 2012, Matrix biology : journal of the International Society for Matrix Biology.
[37] B. Kazmierczak,et al. Innate immune responses to Pseudomonas aeruginosa infection. , 2011, Microbes and infection.
[38] H. Dinh,et al. IL-36R ligands are potent regulators of dendritic and T cells. , 2011, Blood.
[39] C. Gabel,et al. Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity , 2011, The Journal of Biological Chemistry.
[40] P. Avila,et al. Regulation and function of the IL-1 family cytokine IL-1F9 in human bronchial epithelial cells. , 2011, American journal of respiratory cell and molecular biology.
[41] Stephen R Comeau,et al. Achieving reliability and high accuracy in automated protein docking: Cluspro, PIPER, SDU, and stability analysis in CAPRI rounds 13–19 , 2010, Proteins.
[42] C. Watts,et al. Diverse regulatory roles for lysosomal proteases in the immune response , 2009, European journal of immunology.
[43] Nicolas Lützner,et al. Quantifying Cathepsin S Activity in Antigen Presenting Cells Using a Novel Specific Substrate* , 2008, Journal of Biological Chemistry.
[44] Igor Rudan,et al. Epidemiology and etiology of childhood pneumonia. , 2008, Bulletin of the World Health Organization.
[45] A. Rodloff,et al. Acute Respiratory Distress Syndrome and Pneumonia: A Comprehensive Review of Clinical Data , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] M. Laan,et al. Neutrophils, interleukin-17A and lung disease , 2005, European Respiratory Journal.
[47] J. Sims,et al. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 Signal through IL-1Rrp2 and IL-1RAcP to Activate the Pathway Leading to NF-κB and MAPKs* , 2004, Journal of Biological Chemistry.
[48] R. Maki,et al. Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL1R-rp2) , 1996, Journal of Neuroimmunology.
[49] P. Bornstein,et al. Diversity of Function Is Inherent in Matricellular Proteins: an Appraisal of Thrombospondin I , 1995 .
[50] P. Bornstein,et al. Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. , 1991, The Journal of biological chemistry.
[51] M. Iruela-Arispe,et al. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[52] R. Silverstein,et al. Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion. , 1987, The Journal of clinical investigation.
[53] J. Lawler. The structural and functional properties of thrombospondin. , 1986, Blood.
[54] D. Mosher,et al. Localization of thrombospondin in clots formed in situ. , 1985, Blood.
[55] L. Westrick,et al. Incorporation of thrombospondin into fibrin clots. , 1985, The Journal of biological chemistry.
[56] R. Silverstein,et al. Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein. , 1985, The Journal of clinical investigation.
[57] R. Silverstein,et al. Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator. , 1984, The Journal of clinical investigation.
[58] E. Jaffe,et al. Thrombospondin is the endogenous lectin of human platelets , 1982, Nature.
[59] R. Maki,et al. Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1R-rp2). , 1996, Journal of neuroimmunology.
[60] E. Jaffe,et al. Monocytes and macrophages synthesize and secrete thrombospondin. , 1985, Blood.